Left atrioventricular coupling index assessed by 3DE was independently associated with all-cause mortality in patients with light-chain cardiac amyloidosis (adjusted HR 10.58; p=0.008).
Cohort (n=67)
Does the left atrioventricular coupling index (LACI) assessed by 3DE predict all-cause mortality in patients with light-chain cardiac amyloidosis?
3DE-based LACI is an independent predictor of short-term all-cause mortality in patients with light-chain cardiac amyloidosis, adding prognostic value to traditional staging models.
Hazard Ratio: 10.58
p-value: p=0.008
Background Light-chain cardiac amyloidosis (AL-CA) is associated with structural and functional changes in the left atrium and left ventricle. This study aims to assess the value of the left atrioventricular coupling index (LACI) assessed by three-dimensional echocardiography (3DE) for predicting primary outcome in AL-CA.Methods Participants with biopsy-confirmed AL-CA from April 2022 to February 2024 were prospectively analysed. LACI, the ratio of left atrial volume min to left ventricular end-diastolic volumes, was calculated offline using EchoPAC 204. The primary outcome was defined as all-cause death.Results Sixty-seven biopsy-proven AL-CA patients were studied (age: 62.98 ± 10.20 years; 67% male). The median follow-up was 121 days (range: 7 ∼ 732 days). All-cause mortality occurred in 26 (39%) patients. Multivariate Cox regression revealed a significant association of LACI after adjusting for NT-pro BNP, troponin T, moderate tricuspid regurgitation, pericardial and pleural effusion (adjusted HR: 10.58, p = 0.008). Kaplan-Meier curves displayed prognostic differences based on median LACI (cut-off : 0.57, p = 0.002). The likelihood ratio χ2 test showed that LACI added predictive value to Mayo 2004, European 2015 modification of Mayo 2004, and Mayo 2012 models (All p < 0.001).Conclusions 3DE-based LACI is independently associated with all-cause mortality in AL-CA patients and augments prognostic value to traditional staging models.
Meng et al. (Thu,) conducted a cohort in Light-chain cardiac amyloidosis (n=67). Left atrioventricular coupling index (LACI) was evaluated on All-cause death (HR 10.58, p=0.008). Left atrioventricular coupling index assessed by 3DE was independently associated with all-cause mortality in patients with light-chain cardiac amyloidosis (adjusted HR 10.58; p=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: